InsiderTradr

Aspen Pharmacare Holdings Limited (APN.JO)

Johannesburg · ZAc · Healthcare · Drug Manufacturers - Specialty & Generic

ZAC 15,984.00 (+0.40%) as of

Key statistics

Market cap
69.20B
Forward P/E
11.86
EPS (TTM)
-2.00
Dividend yield
1.46%
52-week range
9,070.00 – 16,621.00
Beta
0.52
Revenue (TTM)
34.87B
Profit margin
7.59%
Analyst target
ZAC 17,266.67
Volume
262.15k

About Aspen Pharmacare Holdings Limited

Aspen Pharmacare Holdings Limited, together with its subsidiaries, operates as a specialty and branded pharmaceutical company in Africa, the Middle East, Europe, CIS, Australasia, Asia, and the Americas. It operates through Commercial Pharmaceuticals and Manufacturing segments. The company offers sterile products in injectable form primarily administered in hospitals and prescribed and administered by physicians or in a retail pharmacy environment for therapeutic areas, such as anesthetics, anticoagulants, antithrombotic agents, analgesics, and hormone replacement medicines under the Arixtra, Diprivan, Fraxiparine, Sandostatin, Sustanon, and Xylocaine brands. It also provides over-the-counter topical products through retail pharmacy and fast-moving consumer goods sectors under the EMLA, Maltofer, Ovestin, Solpadeine, and Xylocaine brands; and prescription products for therapeutic areas, including anti-inflammatories, immunosuppressants, hypothyroidism, anti-gout, analgesics, and corticosteroids under the Eltroxin, Imuran, Lipitor, Lyrica, and Meticorten brands. In addition, the company manufactures active pharmaceutical ingredients; finished dose form products manufactured for third parties; and heparin-based API to third parties. Further, it exports its products. Aspen Pharmacare Holdings Limited was founded in 1850 and is headquartered in Durban, South Africa.

Sector
Healthcare
Industry
Drug Manufacturers - Specialty & Generic
Headquarters
Durban, South Africa
Employees
7,283

aspenpharma.com

Financial statements (income statement, balance sheet, cash flow) and an interactive price chart are available on this page with JavaScript enabled.

Related stocks